Free Trial

Ryan Specialty Holdings Inc. (NYSE:RYAN) Receives Consensus Rating of "Moderate Buy" from Analysts

Ryan Specialty logo with Finance background

Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $75.00.

RYAN has been the topic of several research analyst reports. Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. TD Cowen initiated coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. Wells Fargo & Company cut their target price on Ryan Specialty from $65.00 to $63.00 and set an "equal weight" rating on the stock in a research report on Thursday. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and raised their target price for the stock from $74.00 to $81.00 in a research report on Tuesday, May 13th. Finally, Barclays cut their target price on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a research report on Monday, July 7th.

Read Our Latest Stock Report on Ryan Specialty

Insiders Place Their Bets

In related news, Director David P. Bolger sold 5,000 shares of the company's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the transaction, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. This represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Mark Stephen Katz sold 14,377 shares of the company's stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the transaction, the executive vice president owned 1,117 shares of the company's stock, valued at $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.

Hedge Funds Weigh In On Ryan Specialty

Several institutional investors have recently added to or reduced their stakes in the business. Whittier Trust Co. of Nevada Inc. increased its stake in Ryan Specialty by 281.6% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company's stock worth $25,000 after acquiring an additional 245 shares during the last quarter. SVB Wealth LLC acquired a new stake in Ryan Specialty during the first quarter worth about $26,000. Rakuten Securities Inc. acquired a new stake in Ryan Specialty during the fourth quarter worth about $27,000. WPG Advisers LLC acquired a new stake in Ryan Specialty during the first quarter worth about $32,000. Finally, Central Pacific Bank Trust Division purchased a new stake in shares of Ryan Specialty in the second quarter worth about $31,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Stock Performance

Shares of Ryan Specialty stock opened at $63.84 on Friday. The business has a 50-day moving average of $68.08 and a 200 day moving average of $68.11. Ryan Specialty has a 12 month low of $55.95 and a 12 month high of $77.16. The stock has a market capitalization of $16.75 billion, a price-to-earnings ratio of 187.77, a price-to-earnings-growth ratio of 1.72 and a beta of 0.66. The company has a debt-to-equity ratio of 3.45, a current ratio of 1.05 and a quick ratio of 1.05.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting analysts' consensus estimates of $0.39. The company had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. Ryan Specialty's revenue for the quarter was up 25.0% on a year-over-year basis. During the same period last year, the business posted $0.35 EPS. As a group, sell-side analysts forecast that Ryan Specialty will post 2.29 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a yield of 0.75%. Ryan Specialty's payout ratio is 141.18%.

About Ryan Specialty

(Get Free Report

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Articles

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines